WisdomTree BioRevolution Fund (BATS:WDNA – Get Free Report)’s share price shot up 2.6% on Monday . The company traded as high as $17.90 and last traded at $17.90. 171 shares traded hands during mid-day trading, a decline of 82% from the average session volume of 937 shares. The stock had previously closed at $17.44.
WisdomTree BioRevolution Fund Price Performance
The business’s fifty day moving average price is $17.87 and its 200-day moving average price is $16.92. The stock has a market capitalization of $2.69 million, a price-to-earnings ratio of 17.03 and a beta of 1.01.
Hedge Funds Weigh In On WisdomTree BioRevolution Fund
A hedge fund recently raised its stake in WisdomTree BioRevolution Fund stock. Flow Traders U.S. LLC grew its stake in shares of WisdomTree BioRevolution Fund (BATS:WDNA – Free Report) by 59.0% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 26,182 shares of the company’s stock after purchasing an additional 9,720 shares during the period. Flow Traders U.S. LLC owned about 17.45% of WisdomTree BioRevolution Fund worth $416,000 as of its most recent filing with the SEC.
WisdomTree BioRevolution Fund Company Profile
The WisdomTree BioRevolution Fund (WDNA) is an exchange-traded fund that is based on the WisdomTree BioRevolution index. The fund tracks a modified equally-weighted index of companies in developed markets that focus on the advancements in genetics and biotechnology. WDNA was launched on Jun 3, 2021 and is managed by WisdomTree.
Read More
- Five stocks we like better than WisdomTree BioRevolution Fund
- Gold Shock Coming March 18?
- Buy this Gold Stock Before May 15th, 2026
- America’s 1776 happening again
- J.P. Morgan is betting on this coin
- Central banks just did something they haven’t done since 1967
Receive News & Ratings for WisdomTree BioRevolution Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WisdomTree BioRevolution Fund and related companies with MarketBeat.com's FREE daily email newsletter.
